Glial Cell Dysfunction in <i>C9orf72</i>-Related Amyotrophic Lateral Sclerosis and Frontotemporal Dementia

Since the discovery of the chromosome 9 open reading frame 72 (<i>C9orf72</i>) repeat expansion mutation in 2011 as the most common genetic abnormality in amyotrophic lateral sclerosis (ALS, also known as Lou Gehrig’s disease) and frontotemporal dementia (FTD), progress in understanding...

Full description

Bibliographic Details
Main Authors: Mehdi Ghasemi, Kiandokht Keyhanian, Catherine Douthwright
Format: Article
Language:English
Published: MDPI AG 2021-01-01
Series:Cells
Subjects:
Online Access:https://www.mdpi.com/2073-4409/10/2/249
_version_ 1797406584192630784
author Mehdi Ghasemi
Kiandokht Keyhanian
Catherine Douthwright
author_facet Mehdi Ghasemi
Kiandokht Keyhanian
Catherine Douthwright
author_sort Mehdi Ghasemi
collection DOAJ
description Since the discovery of the chromosome 9 open reading frame 72 (<i>C9orf72</i>) repeat expansion mutation in 2011 as the most common genetic abnormality in amyotrophic lateral sclerosis (ALS, also known as Lou Gehrig’s disease) and frontotemporal dementia (FTD), progress in understanding the signaling pathways related to this mutation can only be described as intriguing. Two major theories have been suggested—(i) loss of function or haploinsufficiency and (ii) toxic gain of function from either <i>C9orf72</i> repeat RNA or dipeptide repeat proteins (DPRs) generated from repeat-associated non-ATG (RAN) translation. Each theory has provided various signaling pathways that potentially participate in the disease progression. Dysregulation of the immune system, particularly glial cell dysfunction (mainly microglia and astrocytes), is demonstrated to play a pivotal role in both loss and gain of function theories of <i>C9orf72</i> pathogenesis. In this review, we discuss the pathogenic roles of glial cells in <i>C9orf72</i> ALS/FTD as evidenced by pre-clinical and clinical studies showing the presence of gliosis in <i>C9orf72</i> ALS/FTD, pathologic hallmarks in glial cells, including TAR DNA-binding protein 43 (TDP-43) and p62 aggregates, and toxicity of <i>C9orf72</i> glial cells. A better understanding of these pathways can provide new insights into the development of therapies targeting glial cell abnormalities in <i>C9orf72</i> ALS/FTD.
first_indexed 2024-03-09T03:28:32Z
format Article
id doaj.art-8a002479f86d4af393ef6712ef3e0c32
institution Directory Open Access Journal
issn 2073-4409
language English
last_indexed 2024-03-09T03:28:32Z
publishDate 2021-01-01
publisher MDPI AG
record_format Article
series Cells
spelling doaj.art-8a002479f86d4af393ef6712ef3e0c322023-12-03T14:59:32ZengMDPI AGCells2073-44092021-01-0110224910.3390/cells10020249Glial Cell Dysfunction in <i>C9orf72</i>-Related Amyotrophic Lateral Sclerosis and Frontotemporal DementiaMehdi Ghasemi0Kiandokht Keyhanian1Catherine Douthwright2Department of Neurology, University of Massachusetts Medical School, Worcester, MA 01655, USADepartment of Neurology, University of Massachusetts Medical School, Worcester, MA 01655, USADepartment of Neurology, University of Massachusetts Medical School, Worcester, MA 01655, USASince the discovery of the chromosome 9 open reading frame 72 (<i>C9orf72</i>) repeat expansion mutation in 2011 as the most common genetic abnormality in amyotrophic lateral sclerosis (ALS, also known as Lou Gehrig’s disease) and frontotemporal dementia (FTD), progress in understanding the signaling pathways related to this mutation can only be described as intriguing. Two major theories have been suggested—(i) loss of function or haploinsufficiency and (ii) toxic gain of function from either <i>C9orf72</i> repeat RNA or dipeptide repeat proteins (DPRs) generated from repeat-associated non-ATG (RAN) translation. Each theory has provided various signaling pathways that potentially participate in the disease progression. Dysregulation of the immune system, particularly glial cell dysfunction (mainly microglia and astrocytes), is demonstrated to play a pivotal role in both loss and gain of function theories of <i>C9orf72</i> pathogenesis. In this review, we discuss the pathogenic roles of glial cells in <i>C9orf72</i> ALS/FTD as evidenced by pre-clinical and clinical studies showing the presence of gliosis in <i>C9orf72</i> ALS/FTD, pathologic hallmarks in glial cells, including TAR DNA-binding protein 43 (TDP-43) and p62 aggregates, and toxicity of <i>C9orf72</i> glial cells. A better understanding of these pathways can provide new insights into the development of therapies targeting glial cell abnormalities in <i>C9orf72</i> ALS/FTD.https://www.mdpi.com/2073-4409/10/2/249<i>C9orf72</i> gene<i>C9orf72</i> repeat expansion mutationamyotrophic lateral sclerosis (ALS)frontotemporal dementia (FTD)astrocytesmicroglia
spellingShingle Mehdi Ghasemi
Kiandokht Keyhanian
Catherine Douthwright
Glial Cell Dysfunction in <i>C9orf72</i>-Related Amyotrophic Lateral Sclerosis and Frontotemporal Dementia
Cells
<i>C9orf72</i> gene
<i>C9orf72</i> repeat expansion mutation
amyotrophic lateral sclerosis (ALS)
frontotemporal dementia (FTD)
astrocytes
microglia
title Glial Cell Dysfunction in <i>C9orf72</i>-Related Amyotrophic Lateral Sclerosis and Frontotemporal Dementia
title_full Glial Cell Dysfunction in <i>C9orf72</i>-Related Amyotrophic Lateral Sclerosis and Frontotemporal Dementia
title_fullStr Glial Cell Dysfunction in <i>C9orf72</i>-Related Amyotrophic Lateral Sclerosis and Frontotemporal Dementia
title_full_unstemmed Glial Cell Dysfunction in <i>C9orf72</i>-Related Amyotrophic Lateral Sclerosis and Frontotemporal Dementia
title_short Glial Cell Dysfunction in <i>C9orf72</i>-Related Amyotrophic Lateral Sclerosis and Frontotemporal Dementia
title_sort glial cell dysfunction in i c9orf72 i related amyotrophic lateral sclerosis and frontotemporal dementia
topic <i>C9orf72</i> gene
<i>C9orf72</i> repeat expansion mutation
amyotrophic lateral sclerosis (ALS)
frontotemporal dementia (FTD)
astrocytes
microglia
url https://www.mdpi.com/2073-4409/10/2/249
work_keys_str_mv AT mehdighasemi glialcelldysfunctioninic9orf72irelatedamyotrophiclateralsclerosisandfrontotemporaldementia
AT kiandokhtkeyhanian glialcelldysfunctioninic9orf72irelatedamyotrophiclateralsclerosisandfrontotemporaldementia
AT catherinedouthwright glialcelldysfunctioninic9orf72irelatedamyotrophiclateralsclerosisandfrontotemporaldementia